Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Longer treatment duration, using semaglutide, higher percentage body fat, and nondiabetic status may be associated with better weight reduction.

As she awaited a heart ablation to treat her AFib, Dolores Catania turned to food for comfort. After her procedure, she ...

PolyPid's proprietary and clinically validated, prolonged-release drug delivery technology aims to subcutaneously deliver GLP-1 for approximately 60 days, compared to current standard of care of ...

Research indicates GLP-1 receptor agonists, like Ozempic, may elevate testosterone levels in men while promoting weight loss. A study presented at ENDO 2025 showed a significant increase in ...

Individuals with type 2 diabetes who receive treatment with GLP-1 RAs do not have an increased risk for acute pancreatitis.

GLP-1 receptor agonists such as semaglutide and liraglutide promote significant weight loss and improved glycemic control, ...

Theratechnologies entered a definitive agreement to be acquired by Future Pak. Find out why do not expect to see THTX stock ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

As per the petition, GLP-1-RA drugs were originally developed and internationally ... and absence of a robust pharmacovigilance or regulatory oversight mechanism. It said that there is no evidence to ...

The PIL seeks a ban on the marketing and distribution of specific GLP-1 receptor agonist (RA) drugs, namely Semaglutide, ...